Jefferies Maintains Buy Rating on Insulet, Cuts Price Target to $190
Jefferies maintained its Buy rating on Insulet and cut its price target to $190 per share from $275.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.